Alkem Laboratories Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Vikas Gupta

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managementsless than a year
Durchschnittliche Amtszeit der Vorstandsmitglieder9.3yrs

Jüngste Management Updates

Recent updates

What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Sep 24
What Alkem Laboratories Limited's (NSE:ALKEM) P/E Is Not Telling You

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 03
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Aug 13
Earnings Beat: Alkem Laboratories Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Jan 09
Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Nov 30
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Geschäftsführer

Vikas Gupta

less than a year

Amtszeit

Dr. Vikas Gupta is Chief Executive Officer of Alkem Laboratories Limited from September 22, 2023. He has experience in Pharmaceutical Sector and brings with him deep experience across therapeutic areas inc...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Basudeo Singh
Executive Chairman51.1yrs₹200.60m13.31%
₹ 98.4b
Sarvesh Singh
VP of Sales & Marketing and Executive Directorno data₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Directorless than a year₹81.50m0.0065%
₹ 48.3m
Mritunjay Singh
Executive Directorno data₹104.30m8.58%
₹ 63.5b
Srinivas Singh
Executive Director2yrs₹96.60m0.086%
₹ 635.1m
Madhurima Singh
Executive Directorno data₹104.10m8.77%
₹ 64.9b
Vikas Gupta
Chief Executive Officerless than a yearkeine Datenkeine Daten
Akhilesh Sharma
President & Chief Medical Officerno datakeine Datenkeine Daten
Kaustav Banerjee
President & Head Medtech Businessless than a yearkeine Datenkeine Daten
Rajorshi Ganguli
President & Global HR Headno datakeine Datenkeine Daten
Nitin Agrawal
CFO & President of Financeless than a yearkeine Datenkeine Daten
Satish Singh
Head of Operationsno datakeine Daten0.060%
₹ 444.9m

1.0yrs

Durchschnittliche Betriebszugehörigkeit

55yo

Durchschnittliches Alter

Erfahrenes Management: ALKEMDas Führungsteam des Unternehmens gilt nicht als erfahren (1.2 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Basudeo Singh
Executive Chairman51.1yrs₹200.60m13.31%
₹ 98.4b
Sarvesh Singh
VP of Sales & Marketing and Executive Director4.8yrs₹44.50m0%
₹ 0
Sandeep Singh
MD & Executive Director11.1yrs₹81.50m0.0065%
₹ 48.3m
Mritunjay Singh
Executive Director15.8yrs₹104.30m8.58%
₹ 63.5b
Srinivas Singh
Executive Director2yrs₹96.60m0.086%
₹ 635.1m
Madhurima Singh
Executive Director2.8yrs₹104.10m8.77%
₹ 64.9b
Arun Purwar
Independent Director9.5yrs₹3.30mkeine Daten
Sudha Ravi
Independent Director9.3yrs₹3.10mkeine Daten
Sangeeta Singh
Independent Director9.3yrs₹3.00mkeine Daten
Narendra Aneja
Independent Director4.5yrs₹3.20mkeine Daten
Sujjain Talwar
Independent Director2.1yrs₹2.70mkeine Daten

9.3yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: ALKEMDie Vorstandsmitglieder gelten als erfahren (8 Jahre durchschnittliche Amtszeit).